What Theranos fraudster Elizabeth Holmes’ conviction means for chemistry

By Rebecca Trager2022-01-05T12:20:00

Elizabeth Holmes wearing a face mask and business suit leaving court

Source: © Dai Sugano/MediaNews Group/The Mercury News via Getty Images

Holmes faces up to 65 years in prison for defrauding investors while running her now defunct blood testing startup

The conviction of Elizabeth Holmes, the former chief executive and founder of failed blood-testing startup Theranos on four charges of defrauding investors out of millions of dollars has had reverberations for analytical chemistry, the field of blood monitoring and beyond.